Core Viewpoint - Haike Xinyuan (301292) announced that as of August 31, 2025, the company has not repurchased its shares through a special account for share buybacks via centralized bidding [1] Summary by Category - **Company Announcement** - Haike Xinyuan has not engaged in any share repurchase activities as of the specified date [1]

一、回购事项概述 山东海科新源材料科技股份有限公司（以下简称"公司"） 于2025年8月27日召开了第二届董事会第二十次会议，审议 通过了《关于回购公司股份方案的议案》。公司拟使用自有 资金或回购专项贷款资金以集中竞价交易方式回购公司股 份，回购的资金总额不低于1,100万元（含）且不超过2,200 万元（含），回购股份的价格为不超过30元/股（含），回 购股份拟用于员工持股计划，回购股份的期限自董事会审议 通过本次回购股份方案之日起6个月内。具体内容详见公司 披露的《关于回购公司股份方案的公告》（公告编号： 2025-047）。 二、回购公司股份的进展情况 证券代码：301292 证券简称：海科新源 公告编号：2025-055 山东海科新源材料科技股份有限公司 关于股份回购进展情况的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、 完整，没有虚假记载、误导性陈述或重大遗漏。 根据《公司法》《证券法》《上市公司股份回购规则》 《深圳证券交易所上市公司自律监管指引第9号—回购股份》 等法律法规和规范性文件及《公司章程》的有关规定：在回 购股份期间，上市公司应当在每个月的前三个交易日内，公 告截至上月末 ...

根据《上市公司股份回购规则》《深圳证券交易所上市公司自律 监管指引第9号——回购股份》等法律法规、规范性文件的有关规定， 现将公司董事会公告回购股份决议披露的前一交易日（即2025年8月 27日）登记在册的前十名股东和前十名无限售条件股东的名称、持股 数量、持股比例情况公告如下： 序 号 股东名称 持股数量（股） 占公司总股本比例 （%） 1 山东海科控股有限公司 135,793,999 60.95 一、前十名股东情况（合并普通账户和融资融券信用账户） 证券代码：301292 证券简称：海科新源 公告编号：2025-054 山东海科新源材料科技股份有限公司 关于回购股份事项前十名股东和前十名无限售条件股东持 股情况的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、 完整，没有虚假记载、误导性陈述或重大遗漏。 山东海科新源材料科技股份有限公司(下称"公司")于2025年8 月27日召开第二届董事会第二十次会议，审议通过了《关于回购公司 股份方案的议案》。公司拟使用自有资金或回购专项贷款资金以集中 竞价交易方式回购公司股份，回购的资金总额不低于1,100万元（含） 且不超过2,200万元（含），回购股份 ...

Group 1 - The company Haike Xinyuan (301292) announced it will hold a semi-annual performance briefing on September 5, 2025, from 15:00 to 16:00 via the Tonghuashun (300033) online roadshow platform [1]

（二）出席人员：总经理马立军，财务总监兼董事会秘书尉彬彬， 独立董事肖振宇，保荐代表人钱进（如遇特殊情况，参会人员可能进 行调整）。 证券代码：301292 证券简称：海科新源 公告编号：2025-053 山东海科新源材料科技股份有限公司 关于举办 2025 年半年度业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 山东海科新源材料科技股份有限公司（以下简称"公司"）已于 2025 年 8 月 28 日披露《2025 年半年度报告》。为使投资者能够进一 步了解公司经营成果、财务状况，公司将于 2025 年 9 月 5 日（星期 五）下午 15:00-16:00 在同花顺路演平台采用网络远程方式举行业绩 说明会，现将具体情况公告如下： 一、业绩说明会安排 （一）召开时间：2025 年 9 月 5 日（星期五）15:00-16:00。 三、联系人及咨询方式 （三）召开方式：网络互动方式。 （四）参会方式： 1、登录同花顺路演平台，进入直播间 https://board.10jqka.com.cn/rs/pc/detail?roadshowId=10 ...

Core Viewpoint - Haike Xinyuan reported a significant reduction in losses for the first half of 2025, with a net loss of 42.83 million yuan, compared to a loss of 110 million yuan in the same period last year, indicating improved financial performance despite ongoing challenges [1][3]. Financial Performance - The company achieved an operating revenue of 2.316 billion yuan in the first half of 2025, representing a year-on-year growth of 27.92% from 1.811 billion yuan [3]. - The basic earnings per share improved to -0.19 yuan, up 62.00% from -0.50 yuan in the previous year, reflecting a gradual recovery in earnings capability [3]. - The overall gross margin increased to 3.58%, up 1.82 percentage points from the previous year, indicating effective product structure adjustments and cost control efforts [3]. Cash Flow and Liquidity - The net cash flow from operating activities was -248 million yuan, worsening from -195 million yuan in the same period last year, highlighting ongoing cash flow challenges [1][4]. - As of June 30, 2025, the company's cash and cash equivalents decreased to 822 million yuan, down 55.6% from 1.851 billion yuan at the beginning of the year, indicating weakened immediate payment capabilities [2][4]. Asset and Liability Structure - Total assets decreased to 7.294 billion yuan, down 12.47% from 8.333 billion yuan at the beginning of the year, primarily due to a reduction in cash [4]. - Accounts receivable increased to 1.232 billion yuan, a growth of 30.86% from 941 million yuan, aligning with revenue growth [4]. Market Position and Strategy - Haike Xinyuan is a leading player in the lithium-ion battery electrolyte solvent market, with significant clients including Tesla, BYD, and CATL, and a stable position in the consumer chemicals sector [5]. - The company is expected to benefit from the explosive demand in the new energy vehicle and energy storage markets, with projected growth rates of 20% and over 30%, respectively [7]. - The dual business strategy focusing on lithium battery materials and consumer chemicals is anticipated to further enhance performance, although the effectiveness of this strategy will require ongoing observation [8].

Core Viewpoint - Haike Xinyuan (301292.SZ) reported a significant reduction in losses for the first half of 2025, with a net profit attributable to shareholders of -42.83 million yuan, an improvement of 61.21% compared to a loss of 110 million yuan in the same period last year [1][3]. Financial Performance - The company achieved an operating revenue of 2.316 billion yuan in the first half of 2025, representing a year-on-year growth of 27.92% from 1.811 billion yuan [3]. - The basic earnings per share improved to -0.19 yuan, up 62.00% from -0.50 yuan in the previous year, indicating a gradual recovery in earnings capability [3]. - The overall gross margin increased to 3.58%, up 1.82 percentage points year-on-year, reflecting effective product structure adjustments and cost control efforts [3]. Cash Flow and Liquidity - The net cash flow from operating activities was -248 million yuan, a further decline from -195 million yuan in the same period last year, indicating ongoing cash flow pressures [1][4]. - As of June 30, 2025, the company's cash and cash equivalents were 822 million yuan, down 55.6% from 1.851 billion yuan at the beginning of the year, highlighting weakened immediate payment capabilities [2][4]. Asset and Liability Structure - Total assets decreased by 12.47% to 7.294 billion yuan from 8.333 billion yuan at the beginning of the year [4]. - Accounts receivable rose to 1.232 billion yuan, a 30.86% increase from 941 million yuan at the beginning of the year, aligning with revenue growth [4]. Market Position and Strategy - Haike Xinyuan is a leading global supplier of lithium-ion battery electrolyte solvents, with significant market presence among major clients such as Tesla and BYD [5]. - The company is pursuing a dual business strategy focusing on lithium battery materials and consumer chemicals, which is expected to mitigate risks from industry fluctuations and contribute to stable cash flow [7][8]. - The company is also exploring financing options, including a credit facility of up to 50 million yuan from Weifang Bank, aimed at supporting business development needs [8].

Group 1 - Tianqi Materials reported a revenue of 7.03 billion yuan for the first half of 2025, a year-on-year increase of 28.97% [2][3] - The net profit attributable to shareholders was 268 million yuan, up 12.79% year-on-year, while the net profit excluding non-recurring items was 235 million yuan, reflecting a growth of 26.01% [2][3] - Basic earnings per share increased to 0.14 yuan, a rise of 16.67% compared to the previous year [3] Group 2 - New Zobang achieved a revenue of 4.25 billion yuan, marking an 18.58% increase year-on-year, with a net profit of 484 million yuan, up 16.36% [5][6] - The net profit excluding non-recurring items was 466 million yuan, showing an 8.16% increase [5][6] - Basic earnings per share rose to 0.64 yuan, a 16.36% increase from the previous year [6] Group 3 - Ruida New Materials reported a revenue of 975 million yuan, a decline of 7.36% year-on-year, with a net profit of 82 million yuan, down 24.19% [7][8] - The net profit excluding non-recurring items was 79 million yuan, reflecting a decrease of 27.57% [7][8] - The company experienced a negative cash flow from operating activities of 80 million yuan [8] Group 4 - Yongtai Technology reported a revenue of 2.61 billion yuan, a year-on-year increase of 21.97%, with a net profit of 59 million yuan, up 56.17% [10][11] - The net profit excluding non-recurring items was 23 million yuan, down 15.08% [10][11] - Basic earnings per share increased to 0.06 yuan, a 50% rise compared to the previous year [11] Group 5 - Shida Shenghua reported a revenue of 3.01 billion yuan, a year-on-year increase of 14.87%, but a net loss of 56 million yuan, a decline of 248.03% [13][14] - The net loss excluding non-recurring items was 57 million yuan, down 282.11% [13][14] - The company reported a positive cash flow from operating activities of 90 million yuan [14] Group 6 - Duofluor reported a revenue of 4.33 billion yuan, a decline of 6.65% year-on-year, with a net profit of 51 million yuan, down 16.55% [15][16] - The net profit excluding non-recurring items was a loss of 4.81 million yuan, reflecting a decrease of 179.71% [15][16] - Basic earnings per share decreased to 0.0441 yuan, down 15.19% [16] Group 7 - Tianji Co. reported a revenue of 1.07 billion yuan, a year-on-year increase of 19.16%, but a net loss of 52 million yuan, an improvement of 59% compared to the previous year [18][19] - The net loss excluding non-recurring items was 56 million yuan, down 56.04% [18][19] - The company reported a negative cash flow from operating activities of 131 million yuan [19] Group 8 - Huayu Pharmaceutical reported a revenue of 882 million yuan, a decline of 1.73% year-on-year, with a net loss of 5.81 million yuan, a decline of 116.23% [21][22] - The net loss excluding non-recurring items was 21.59 million yuan, down 247.06% [21][22] - The company reported a negative cash flow from operating activities of 169 million yuan [22] Group 9 - Haike New Source reported a revenue of 2.32 billion yuan, a year-on-year increase of 27.92%, but a net loss of 42 million yuan, an improvement of 61.21% [23][24] - The net loss excluding non-recurring items was 49 million yuan, down 56.57% [23][24] - The company reported a negative cash flow from operating activities of 248 million yuan [24] Group 10 - Hualu Hengsheng reported a revenue of 15.76 billion yuan, a decline of 7.14% year-on-year, with a net profit of 1.57 billion yuan, down 29.47% [26][27] - The net profit excluding non-recurring items was 1.56 billion yuan, reflecting a decrease of 30.29% [26][27] - Basic earnings per share decreased to 0.739 yuan, down 29.48% [27] Group 11 - Huasheng Lithium reported a revenue of 349 million yuan, a year-on-year increase of 72.02%, but a net loss of 72 million yuan [29] - The net profit excluding non-recurring items was a loss of 78 million yuan [29] - The company reported a negative cash flow from operating activities of 183 million yuan [29] Group 12 - Fuxiang Pharmaceutical reported a revenue of 514 million yuan, a decline of 24.58% year-on-year, with a net loss of 6.91 million yuan, an increase of 69.23% [31][32] - The net loss excluding non-recurring items was 32 million yuan, reflecting a decrease of 34.91% [31][32] - The company reported a negative cash flow from operating activities of 10 million yuan [32] Group 13 - Furui Co. reported a revenue of 2.59 billion yuan, a decline of 3.03% year-on-year, but a net profit of 246 million yuan, an increase of 10.92% [34][35] - The net profit excluding non-recurring items was 250 million yuan, reflecting a growth of 15.71% [34][35] - The company reported a positive cash flow from operating activities of 447 million yuan [35] Group 14 - The overall performance of companies in the electrolyte and raw material sector has been poor, with most companies reporting unsatisfactory financial results [36] - Except for Tianqi and New Zobang, other companies in the electrolyte sector have shown average performance [36] - Companies in the lithium hexafluorophosphate sector have reported significant losses, with net profits declining across the board [36]

Core Viewpoint - Haike Xinyuan (301292) reported a significant increase in revenue and a reduction in net loss for the first half of 2025, indicating improved profitability and operational efficiency [1] Financial Performance - Total revenue for the first half of 2025 reached 2.316 billion yuan, a year-on-year increase of 27.92% compared to 1.811 billion yuan in 2024 [1] - The net profit attributable to shareholders was -42.83 million yuan, showing a 61.21% improvement from -110 million yuan in the previous year [1] - The gross margin increased to 3.58%, up 104.12% from 1.75% in 2024, while the net margin improved to -2.32%, a 68.65% increase from -7.39% [1] - Total expenses (selling, administrative, and financial) amounted to 67.23 million yuan, accounting for 2.9% of revenue, a decrease of 47.62% year-on-year [1] Cash Flow and Debt Management - Cash flow per share was -1.11 yuan, down 27.54% from -0.87 yuan in 2024, indicating challenges in cash generation [1] - The company’s interest-bearing debt decreased to 2.81 billion yuan, a reduction of 11.06% from 3.16 billion yuan [1] - The ratio of cash to current liabilities was only 41.2%, raising concerns about liquidity [3] Research and Development - The company invested 152 million yuan in R&D in 2024, representing 4.22% of revenue, and has obtained 128 patents [6] - Focus areas for R&D include lithium battery electrolyte materials and consumer chemicals, with ongoing efforts in solid-state battery electrolytes and high-purity chemicals [6] Market Position and Strategy - The company has entered the supply chains of major players like Tesla and CATL, aiming to enhance its international presence and operational efficiency [5] - A dual-driven development model of "lithium battery materials + consumer chemicals" is being pursued to strengthen core competitiveness [5] - The company plans to expand its market share through technological innovation and strategic international market development [5]

Group 1 - The core point of the article is that Shandong Haike New Source Material Technology Co., Ltd. has received a loan commitment from Industrial and Commercial Bank of China (ICBC) to support its share repurchase plan [1][3]. - The company plans to use its own funds or the special loan funds for share repurchase, with a total repurchase amount not less than 11 million yuan (approximately 1.1 million) and not exceeding 22 million yuan (approximately 2.2 million), at a price not exceeding 30 yuan per share [2][4]. - The loan commitment from ICBC is capped at 19.8 million yuan (approximately 1.98 million) with a loan term of up to 3 years [3]. Group 2 - The receipt of the loan commitment provides strong financial support for the company's share repurchase, but it does not guarantee the actual amount of shares to be repurchased, which will depend on the implementation of the repurchase plan and market conditions [4].